Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043017 · ClinicalTrials.gov registry record · Phase 2
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
A Phase 2 study, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 356
- Enrollment target
NCT00043017 is a Phase 2 study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 356 participants.
The verdict
NCT00043017, a Phase 2 study, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 356 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study the effectiveness of MRI in monitoring tumor response in women who are receiving chemotherapy for stage III breast cancer.
Interventions
- RADIATION gadopentetate dimeglumine
- PROCEDURE MRI/MRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2002-05 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00043017
The ClinicalTrials.gov registry entry for NCT00043017 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 356 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gadopentetate dimeglumine is the first listed.
NCT00043017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00043017 about?
NCT00043017 is a clinical study titled "Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer". RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study the effectiveness of MRI in monitoring tumor response in wom...
What is the current status of trial NCT00043017?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 356 participants. The study started on 2002-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00043017?
The interventions under investigation include: gadopentetate dimeglumine (RADIATION), MRI/MRS (PROCEDURE).
Who is sponsoring clinical trial NCT00043017?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.